|
1
|
Lusis AJ: Atherosclerosis. Nature.
407:233–241. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gittenberger-de Groot AC, DeRuiter MC,
Bergwerff M and Poelmann RE: Smooth muscle cell origin and its
relation to heterogeneity in development and disease. Arterioscler
Thromb Vasc Biol. 19:1589–1594. 1999.PubMed/NCBI
|
|
3
|
Frid MG, Dempsey EC, Durmowicz AG and
Stenmark KR: Smooth muscle cell heterogeneity in pulmonary and
systemic vessels. Importance in vascular disease. Arterioscler
Thromb Vasc Biol. 17:1203–1209. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schachter M: Vascular smooth muscle cell
migration, atherosclerosis, and calcium channel blockers. Int J
Cardiol. 62(Suppl 2): S85–S90. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Libby P, Sukhova G, Lee RT and Liao JK:
Molecular biology of atherosclerosis. Int J Cardiol. 62(Suppl 2):
S23–S29. 1997. View Article : Google Scholar
|
|
6
|
Schwartz SM: Smooth muscle migration in
atherosclerosis and restenosis. J Clin Invest. 100(Suppl): S87–S89.
1997.PubMed/NCBI
|
|
7
|
Doran AC, Meller N and McNamara CA: Role
of smooth muscle cells in the initiation and early progression of
atherosclerosis. Arterioscler Thromb Vasc Biol. 28:812–819. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huntzinger E and Izaurralde E: Gene
silencing by microRNAs: contributions of translational repression
and mRNA decay. Nat Rev Genet. 12:99–110. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cho WC: OncomiRs: the discovery and
progress of microRNAs in cancers. Mol Cancer. 6:602007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Small EM and Olson EN: Pervasive roles of
microRNAs in cardiovascular biology. Nature. 469:336–342. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Song Z and Li G: Role of specific
microRNAs in regulation of vascular smooth muscle cell
differentiation and the response to injury. J Cardiovasc Transl
Res. 3:246–250. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zernecke A: MicroRNAs in the regulation of
immune cell functions-implications for atherosclerotic vascular
disease. Thromb Haemost. 107:626–633. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Aghabozorg Afjeh SS and Ghaderian SM: The
role of microRNAs in cardiovascular disease. Int J Mol Cell Med.
2:50–57. 2013.PubMed/NCBI
|
|
14
|
Robinson HC and Baker AH: How do microRNAs
affect vascular smooth muscle cell biology? Curr Opin Lipidol.
23:405–411. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Owens GK, Kumar MS and Wamhoff BR:
Molecular regulation of vascular smooth muscle cell differentiation
in development and disease. Physiol Rev. 84:767–801. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Stegemann JP, Hong H and Nerem RM:
Mechanical, biochemical, and extracellular matrix effects on
vascular smooth muscle cell phenotype. J Appl Physiol (1985).
98:2321–2327. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tang Y, Yang X, Friesel RE, Vary CP and
Liaw L: Mechanisms of TGF-β-induced differentiation in human
vascular smooth muscle cells. J Vasc Res. 48:485–494. 2011.
|
|
18
|
Millette E, Rauch BH, Kenagy RD, Daum G
and Clowes AW: Platelet-derived growth factor-BB transactivates the
fibroblast growth factor receptor to induce proliferation in human
smooth muscle cells. Trends Cardiovasc Med. 16:25–28. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Raines EW: PDGF and cardiovascular
disease. Cytokine Growth Factor Rev. 15:237–254. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ross R: The pathogenesis of
atherosclerosis: a perspective for the 1990s. Nature. 362:801–809.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen J, Yin H, Jiang Y, et al: Induction
of microRNA-1 by myocardin in smooth muscle cells inhibits cell
proliferation. Arterioscler Thromb Vasc Biol. 31:368–375. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xie C, Huang H, Sun X, et al: MicroRNA-1
regulates smooth muscle cell differentiation by repressing
Kruppel-like factor 4. Stem Cells Dev. 20:205–210. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jiang Y, Yin H and Zheng XL: MicroRNA-1
inhibits myocardin-induced contractility of human vascular smooth
muscle cells. J Cell Physiol. 225:506–511. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Suzuki T, Aizawa K, Matsumura T and Nagai
R: Vascular implications of the Kruppel-like family of
transcription factors. Arterioscler Thromb Vasc Biol. 25:1135–1141.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu Y, Sinha S, McDonald OG, Shang Y,
Hoofnagle MH and Owens GK: Kruppel-like factor 4 abrogates
myocardin-induced activation of smooth muscle gene expression. J
Biol Chem. 280:9719–9727. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yoshida T, Kaestner KH and Owens GK:
Conditional deletion of Kruppel-like factor 4 delays downregulation
of smooth muscle cell differentiation markers but accelerates
neointimal formation following vascular injury. Circ Res.
102:1548–1557. 2008. View Article : Google Scholar
|
|
27
|
King KE, Iyemere VP, Weissberg PL and
Shanahan CM: Kruppel-like factor 4 (KLF4/GKLF) is a target of bone
morphogenetic proteins and transforming growth factor beta 1 in the
regulation of vascular smooth muscle cell phenotype. J Biol Chem.
278:11661–11669. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang C, Han M, Zhao XM and Wen JK:
Kruppel-like factor 4 is required for the expression of vascular
smooth muscle cell differentiation marker genes induced by
all-trans retinoic acid. J Biochem. 144:313–321. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Katakami N, Kaneto H, Hao H, et al: Role
of pim-1 in smooth muscle cell proliferation. J Biol Chem.
279:54742–54749. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang J, Yan CH, Li Y, et al: MicroRNA-31
controls phenotypic modulation of human vascular smooth muscle
cells by regulating its target gene cellular repressor of
E1A-stimulated genes. Exp Cell Res. 319:1165–1175. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Han Y, Deng J, Guo L, et al: CREG promotes
a mature smooth muscle cell phenotype and reduces neointimal
formation in balloon-injured rat carotid artery. Cardiovasc Res.
78:597–604. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Torella D, Iaconetti C, Catalucci D, et
al: MicroRNA-133 controls vascular smooth muscle cell phenotypic
switch in vitro and vascular remodeling in vivo. Circ Res.
109:880–893. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fichtlscherer S, De Rosa S, Fox H, et al:
Circulating microRNAs in patients with coronary artery disease.
Circ Res. 107:677–684. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Miano JM: Serum response factor: toggling
between disparate programs of gene expression. J Mol Cell Cardiol.
35:577–593. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Madsen CS, Hershey JC, Hautmann MB, White
SL and Owens GK: Expression of the smooth muscle myosin heavy chain
gene is regulated by a negative-acting GC-rich element located
between two positive-acting serum response factor-binding elements.
J Biol Chem. 272:6332–6340. 1997. View Article : Google Scholar
|
|
36
|
Deaton RA, Gan Q and Owens GK:
Sp1-dependent activation of KLF4 is required for PDGF-BB-induced
phenotypic modulation of smooth muscle. Am J Physiol Heart Circ
Physiol. 296:H1027–H1037. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cordes KR, Sheehy NT, White MP, et al:
miR-145 and miR-143 regulate smooth muscle cell fate and
plasticity. Nature. 460:705–710. 2009.PubMed/NCBI
|
|
38
|
Raitoharju E, Lyytikäinen LP, Levula M, et
al: miR-21, miR-210, miR-34a, and miR-146a/b are upregulated in
human atherosclerotic plaques in the Tampere Vascular Study.
Atherosclerosis. 219:211–217. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hergenreider E, Heydt S, Tréguer K, et al:
Atheroprotective communication between endothelial cells and smooth
muscle cells through miRNAs. Nat Cell Biol. 14:249–256. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lovren F, Pan Y, Quan A, et al:
MicroRNA-145 targeted therapy reduces atherosclerosis. Circulation.
126(Suppl 1): S81–S90. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Boettger T, Beetz N, Kostin S, et al:
Acquisition of the contractile phenotype by murine arterial smooth
muscle cells depends on the Mir143/145 gene cluster. J Clin Invest.
119:2634–2647. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Rangrez AY, Massy ZA, Metzinger-Le Meuth V
and Metzinger L: miR-143 and miR-145: molecular keys to switch the
phenotype of vascular smooth muscle cells. Circ Cardiovasc Genet.
4:197–205. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chan MC, Hilyard AC, Wu C, et al:
Molecular basis for antagonism between PDGF and the TGFbeta family
of signalling pathways by control of miR-24 expression. EMBO J.
29:559–573. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chan MC, Nguyen PH, Davis BN, et al: A
novel regulatory mechanism of the bone morphogenetic protein (BMP)
signaling pathway involving the carboxyl-terminal tail domain of
BMP type II receptor. Mol Cell Biol. 27:5776–5789. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Leeper NJ, Raiesdana A, Kojima Y, et al:
MicroRNA-26a is a novel regulator of vascular smooth muscle cell
function. J Cell Physiol. 226:1035–1043. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Liu X, Cheng Y, Zhang S, Lin Y, Yang J and
Zhang C: A necessary role of miR-221 and miR-222 in vascular smooth
muscle cell proliferation and neointimal hyperplasia. Circ Res.
104:476–487. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Davis BN, Hilyard AC, Nguyen PH, Lagna G
and Hata A: Induction of microRNA-221 by platelet-derived growth
factor signaling is critical for modulation of vascular smooth
muscle phenotype. J Biol Chem. 284:3728–3738. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Liu X, Cheng Y, Yang J, Xu L and Zhang C:
Cell-specific effects of miR-221/222 in vessels: molecular
mechanism and therapeutic application. J Mol Cell Cardiol.
52:245–255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Tanner FC, Yang ZY, Duckers E, Gordon D,
Nabel GJ and Nabel EG: Expression of cyclin-dependent kinase
inhibitors in vascular disease. Circ Res. 82:396–403. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Stewart MC, Kadlcek RM, Robbins PD,
MacLeod JN and Ballock RT: Expression and activity of the CDK
inhibitor p57Kip2 in chondrocytes undergoing hypertrophic
differentiation. J Bone Miner Res. 19:123–132. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ashman LK: The biology of stem cell factor
and its receptor c-kit. Int J Biochem Cell Biol. 31:1037–1051.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yang G, Pei Y, Cao Q and Wang R:
MicroRNA-21 represses human cystathionine gamma-lyase expression by
targeting at specificity protein-1 in smooth muscle cells. J Cell
Physiol. 227:3192–3200. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ji R, Cheng Y, Yue J, et al: MicroRNA
expression signature and antisense-mediated depletion reveal an
essential role of microRNA in vascular neointimal lesion formation.
Circ Res. 100:1579–1588. 2007. View Article : Google Scholar
|
|
54
|
Davis BN, Hilyard AC, Lagna G and Hata A:
SMAD proteins control DROSHA-mediated microRNA maturation. Nature.
454:56–61. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ozpolat B, Akar U, Steiner M, et al:
Programmed cell death-4 tumor suppressor protein contributes to
retinoic acid-induced terminal granulocytic differentiation of
human myeloid leukemia cells. Mol Cancer Res. 5:95–108. 2007.
View Article : Google Scholar
|
|
56
|
Cash AC and Andrews J: Fine scale analysis
of gene expression in Drosophila melanogaster gonads reveals
programmed cell death 4 promotes the differentiation of female
germline stem cells. BMC Dev Biol. 12:42012.
|
|
57
|
Curcio A, Torella D and Indolfi C:
Mechanisms of smooth muscle cell proliferation and endothelial
regeneration after vascular injury and stenting: approach to
therapy. Circ J. 75:1287–1296. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Liu X, Cheng Y, Chen X, Yang J, Xu L and
Zhang C: MicroRNA-31 regulated by the extracellular regulated
kinase is involved in vascular smooth muscle cell growth via large
tumor suppressor homolog 2. J Biol Chem. 286:42371–42380. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
An Y, Kang Q, Zhao Y, Hu X and Li N: Lats2
modulates adipocyte proliferation and differentiation via hippo
signaling. PloS One. 8:e720422013. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Wu WH, Hu CP, Chen XP, et al:
MicroRNA-130a mediates proliferation of vascular smooth muscle
cells in hypertension. Am J Hypertens. 24:1087–1093. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Weir L, Chen D, Pastore C, Isner JM and
Walsh K: Expression of gax, a growth arrest homeobox gene, is
rapidly downregulated in the rat carotid artery during the
proliferative response to balloon injury. J Biol Chem.
270:5457–5461. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Xia S, Tai X, Wang Y, et al: Involvement
of Gax gene in hypoxia-induced pulmonary hypertension,
proliferation, and apoptosis of arterial smooth muscle cells. Am J
Respir Cell Mol Biol. 44:66–73. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Saito T, Itoh H, Yamashita J, et al:
Angiotensin II suppresses growth arrest specific homeobox (Gax)
expression via redox-sensitive mitogen-activated protein kinase
(MAPK). Regul Pept. 127:159–167. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Gorski DH, LePage DF, Patel CV, Copeland
NG, Jenkins NA and Walsh K: Molecular cloning of a diverged
homeobox gene that is rapidly downregulated during the G0/G1
transition in vascular smooth muscle cells. Mol Cell Biol.
13:3722–3733. 1993.PubMed/NCBI
|
|
65
|
Yamashita J, Itoh H, Ogawa Y, et al:
Opposite regulation of Gax homeobox expression by angiotensin II
and C-type natriuretic peptide. Hypertension. 29:381–387. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Witzenbichler B, Kureishi Y, Luo Z, Le
Roux A, Branellec D and Walsh K: Regulation of smooth muscle cell
migration and integrin expression by the Gax transcription factor.
J Clin Invest. 104:1469–1480. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Wassmann S, Wassmann K, Jung A, et al:
Induction of p53 by GKLF is essential for inhibition of
proliferation of vascular smooth muscle cells. J Mol Cell Cardiol.
43:301–307. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Sun SG, Zheng B, Han M, et al: miR-146a
and Krüppel-like factor 4 form a feedback loop to participate in
vascular smooth muscle cell proliferation. EMBO Rep. 12:56–62.
2011.
|
|
69
|
Zhang Y, Wang Y, Wang X, et al: Insulin
promotes vascular smooth muscle cell proliferation via
microRNA-208-mediated downregulation of p21. J Hypertens.
29:1560–1568. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Zheng X, Li A, Zhao L, et al: Key role of
microRNA-15a in the KLF4 suppressions of proliferation and
angiogenesis in endothelial and vascular smooth muscle cells.
Biochem Biophys Res Commun. 437:625–631. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Cheng Y, Liu X, Yang J, et al:
MicroRNA-145, a novel smooth muscle cell phenotypic marker and
modulator, controls vascular neointimal lesion formation. Circ Res.
105:158–166. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Quintavalle M, Elia L, Condorelli G and
Courtneidge SA: MicroRNA control of podosome formation in vascular
smooth muscle cells in vivo and in vitro. J Cell Biol. 189:13–22.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Wang YS, Chou WW, Chen KC, Cheng HY, Lin
RT and Juo SH: MicroRNA-152 mediates DNMT1-regulated DNA
methylation in the estrogen receptor α gene. PloS One.
7:e306352012.PubMed/NCBI
|
|
74
|
Li E, Bestor TH and Jaenisch R: Targeted
mutation of the DNA methyltransferase gene results in embryonic
lethality. Cell. 69:915–926. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Huang RS, Hu GQ, Lin B, Lin ZY and Sun CC:
MicroRNA-155 silencing enhances inflammatory response and lipid
uptake in oxidized low-density lipoprotein-stimulated human THP-1
macrophages. J Investig Med. 58:961–967. 2010.PubMed/NCBI
|
|
76
|
Ma X, Ma C and Zheng X: MicroRNA-155 in
the pathogenesis of atherosclerosis: a conflicting role? Heart Lung
Circ. 22:811–818. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Remus EW, Lyle AN, Weiss D, et al: miR181a
protects against angiotensin II-induced osteopontin expression in
vascular smooth muscle cells. Atherosclerosis. 228:168–174. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Wang YS, Wang HY, Liao YC, et al:
MicroRNA-195 regulates vascular smooth muscle cell phenotype and
prevents neointimal formation. Cardiovasc Res. 95:517–526. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Ammit AJ and Panettieri RA Jr: Invited
review: the circle of life: cell cycle regulation in airway smooth
muscle. J Appl Physiol (1985). 91:1431–1437. 2001.PubMed/NCBI
|
|
80
|
Chotani MA, Touhalisky K and Chiu IM: The
small GTPases Ras, Rac, and Cdc42 transcriptionally regulate
expression of human fibroblast growth factor 1. J Biol Chem.
275:30432–30438. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Lindner V and Reidy MA: Proliferation of
smooth muscle cells after vascular injury is inhibited by an
antibody against basic fibroblast growth factor. Proc Natl Acad Sci
USA. 88:3739–3743. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Hanna AK, Fox JC, Neschis DG, Safford SD,
Swain JL and Golden MA: Antisense basic fibroblast growth factor
gene transfer reduces neointimal thickening after arterial injury.
J Vasc Surg. 25:320–325. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Merlet E, Atassi F, Motiani RK, et al:
miR-424/322 regulates vascular smooth muscle cell phenotype and
neointimal formation in the rat. Cardiovasc Res. 98:458–468. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Liu Q, Fu H, Sun F, et al: miR-16 family
induces cell cycle arrest by regulating multiple cell cycle genes.
Nucleic acids Res. 36:5391–5404. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Sahoo SK, Kim T, Kang GB, Lee JG, Eom SH
and Kim do H: Characterization of calumenin-SERCA2 interaction in
mouse cardiac sarcoplasmic reticulum. J Biol Chem. 284:31109–31121.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Sun Y, Chen D, Cao L, et al: miR-490-3p
modulates the proliferation of vascular smooth muscle cells induced
by ox-LDL through targeting PAPP-A. Cardiovasc Res. 100:272–279.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Li P, Liu Y, Yi B, et al: MicroRNA-638 is
highly expressed in human vascular smooth muscle cells and inhibits
PDGF-BB-induced cell proliferation and migration through targeting
orphan nuclear receptor NOR1. Cardiovasc Res. 99:185–193. 2013.
View Article : Google Scholar
|
|
88
|
Bonta PI, Pols TW and de Vries CJ: NR4A
nuclear receptors in atherosclerosis and vein-graft disease. Trends
Cardiovasc Med. 17:105–111. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Yu ML, Wang JF, Wang GK, et al: Vascular
smooth muscle cell proliferation is influenced by let-7d microRNA
and its interaction with KRAS. Circ J. 75:703–709. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Doe Z, Fukumoto Y, Takaki A, et al:
Evidence for Rho-kinase activation in patients with pulmonary
arterial hypertension. Circ J. 73:1731–1739. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Zhou YC and Waxman DJ: Cross-talk between
janus kinase-signal transducer and activator of transcription
(JAK-STAT) and peroxisome proliferator-activated receptor-alpha
(PPARalpha) signaling pathways. Growth hormone inhibition of
pparalpha transcriptional activity mediated by stat5b. J Biol Chem.
274:2672–2681. 1999.
|
|
92
|
Chen KC, Hsieh IC, Hsi E, et al: Negative
feedback regulation between microRNA let-7g and the oxLDL receptor
LOX-1. J Cell Sci. 124:4115–4124. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Mehta JL, Chen J, Hermonat PL, Romeo F and
Novelli G: Lectin-like, oxidized low-density lipoprotein receptor-1
(LOX-1): a critical player in the development of atherosclerosis
and related disorders. Cardiovasc Res. 69:36–45. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Mehta JL and Li DY: Identification and
autoregulation of receptor for OX-LDL in cultured human coronary
artery endothelial cells. Biochem Biophys Res Commun. 248:511–514.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Tan KS, Armugam A, Sepramaniam S, et al:
Expression profile of MicroRNAs in young stroke patients. PloS One.
4:e76892009. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Urbich C, Kuehbacher A and Dimmeler S:
Role of microRNAs in vascular diseases, inflammation, and
angiogenesis. Cardiovasc Res. 79:581–588. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Chen KC, Wang YS, Hu CY, et al: OxLDL
upregulates microRNA-29b, leading to epigenetic modifications of
MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases.
FASEB J. 25:1718–1728. 2011. View Article : Google Scholar
|
|
98
|
Aoyagi M, Yamamoto M, Azuma H, et al:
Immunolocalization of matrix metalloproteinases in rabbit carotid
arteries after balloon denudation. Histochem Cell Biol. 109:97–102.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Gimona M, Kaverina I, Resch GP, Vignal E
and Burgstaller G: Calponin repeats regulate actin filament
stability and formation of podosomes in smooth muscle cells. Mol
Biol Cell. 14:2482–2491. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Linder S and Aepfelbacher M: Podosomes:
adhesion hot-spots of invasive cells. Trends Cell Biol. 13:376–385.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Kunugi S, Iwabuchi S, Matsuyama D, Okajima
T and Kawahara K: Negative-feedback regulation of ATP release: ATP
release from cardiomyocytes is strictly regulated during ischemia.
Biochem Biophys Res Commun. 416:409–415. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Bennett MR: Apoptosis of vascular smooth
muscle cells in vascular remodelling and atherosclerotic plaque
rupture. Cardiovasc Res. 41:361–368. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Fuster V: Lewis A. Conner Memorial
Lecture. Mechanisms leading to myocardial infarction: insights from
studies of vascular biology. Circulation. 90:2126–2146.
1994.PubMed/NCBI
|
|
104
|
Davies MJ, Richardson PD, Woolf N, Katz DR
and Mann J: Risk of thrombosis in human atherosclerotic plaques:
role of extracellular lipid, macrophage, and smooth muscle cell
content. Br Heart J. 69:377–381. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Geng YJ and Libby P: Evidence for
apoptosis in advanced human atheroma. Colocalization with
interleukin-1 beta-converting enzyme. Am J Pathol. 147:251–266.
1995.PubMed/NCBI
|
|
106
|
Sedding DG, Widmer-Teske R, Mueller A, et
al: Role of the phosphatase PTEN in early vascular remodeling. PloS
One. 8:e554452013. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Geng YJ: Molecular signal transduction in
vascular cell apoptosis. Cell Res. 11:253–264. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Clowes AW, Clowes MM, Fingerle J and Reidy
MA: Regulation of smooth muscle cell growth in injured artery. J
Cardiovasc Pharmacol. 14(Suppl 6): S12–S15. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Li W, Liu G, Chou IN and Kagan HM:
Hydrogen peroxide-mediated, lysyl oxidase-dependent chemotaxis of
vascular smooth muscle cells. J Cell Biochem. 78:550–557. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Lazarus HM, Cruikshank WW, Narasimhan N,
Kagan HM and Center DM: Induction of human monocyte motility by
lysyl oxidase. Matrix Biol. 14:727–731. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Kothapalli D, Liu SL, Bae YH, et al:
Cardiovascular protection by ApoE and ApoE-HDL linked to
suppression of ECM gene expression and arterial stiffening. Cell
Rep. 2:1259–1271. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Iyemere VP, Proudfoot D, Weissberg PL and
Shanahan CM: Vascular smooth muscle cell phenotypic plasticity and
the regulation of vascular calcification. J Intern Med.
260:192–210. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Du Y, Gao C, Liu Z, et al: Upregulation of
a disintegrin and metalloproteinase with thrombospondin motifs-7 by
miR-29 repression mediates vascular smooth muscle calcification.
Arterioscler Thromb Vasc Biol. 32:2580–2588. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Wang L, Zheng J, Bai X, et al: ADAMTS-7
mediates vascular smooth muscle cell migration and neointima
formation in balloon-injured rat arteries. Circ Res. 104:688–698.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Liu CJ, Kong W, Ilalov K, et al: ADAMTS-7:
a metalloproteinase that directly binds to and degrades cartilage
oligomeric matrix protein. FASEB J. 20:988–990. 2006. View Article : Google Scholar
|
|
116
|
Du Y, Wang Y, Wang L, et al: Cartilage
oligomeric matrix protein inhibits vascular smooth muscle
calcification by interacting with bone morphogenetic protein-2.
Circ Res. 108:917–928. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Villeneuve LM, Kato M, Reddy MA, Wang M,
Lanting L and Natarajan R: Enhanced levels of microRNA-125b in
vascular smooth muscle cells of diabetic db/db mice lead to
increased inflammatory gene expression by targeting the histone
methyltransferase Suv39h1. Diabetes. 59:2904–2915. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Goettsch C, Rauner M, Pacyna N, Hempel U,
Bornstein SR and Hofbauer LC: miR-125b regulates calcification of
vascular smooth muscle cells. Ame J Pathol. 179:1594–1600. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Zhu F, Friedman MS, Luo W, Woolf P and
Hankenson KD: The transcription factor osterix (SP7) regulates
BMP6-induced human osteoblast differentiation. J Cell Physiol.
227:2677–2685. 2012. View Article : Google Scholar : PubMed/NCBI
|
